{"auto_keywords": [{"score": 0.045693275459193064, "phrase": "wes"}, {"score": 0.00481495049065317, "phrase": "recurrent_allelic_imbalance"}, {"score": 0.004589763483242731, "phrase": "whole-exome_sequencing_data"}, {"score": 0.004481132747216135, "phrase": "whole-exome_sequencing"}, {"score": 0.004023120753104693, "phrase": "cancer_genome_studies"}, {"score": 0.0036993855514735746, "phrase": "wes_data"}, {"score": 0.002741091312632307, "phrase": "user-friendly_and_flexible_software"}, {"score": 0.0026126405272417783, "phrase": "low-quality_datasets"}, {"score": 0.0024311346712789553, "phrase": "statistical_approach"}, {"score": 0.002373472641477602, "phrase": "exomeai"}, {"score": 0.0022085455097790537, "phrase": "recurrent_ai_events"}, {"score": 0.0021561514733516676, "phrase": "wes_datasets"}, {"score": 0.0021049977753042253, "phrase": "specifically_where_matched_normal_samples"}], "paper_keywords": [""], "paper_abstract": "Whole-exome sequencing (WES) has extensively been used in cancer genome studies; however, the use of WES data in the study of loss of heterozygosity or more generally allelic imbalance (AI) has so far been very limited, which highlights the need for user-friendly and flexible software that can handle low-quality datasets. We have developed a statistical approach, ExomeAI, for the detection of recurrent AI events using WES datasets, specifically where matched normal samples are not available.", "paper_title": "ExomeAI: detection of recurrent allelic imbalance in tumors using whole-exome sequencing data", "paper_id": "WOS:000350058800022"}